Forian Inc. is a healthtech company. The Company is a provider of data science-driven information and analytics solutions to the life science, healthcare and financial services industries. The Company provides a suite of data management capabilities and proprietary information and analytics solutions to optimize and measure the operational, clinical and financial performance of customers. It has expertise in acquiring, integrating, normalizing and commercializing large-scale healthcare data assets. Its data ingestion, transformation, delivery services and business intelligence platforms are managed entirely via cloud-based data centers located in the United States. The Company’s offerings include commercial, Real World Evidence (RWE) and market access solutions and proprietary data-driven insights to optimize the operational, clinical and financial performance of its customers. The Company’s solutions include CHRONOS, Chartis, RWE and Kyber Data Science.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 42.61% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 30.26M.
Fairly Valued
The company’s latest PE is -23.49, at a medium 3-year percentile range.
Institutional Buying
The latest institutional holdings are 4.40M shares, increasing 8.00% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 56.00K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.21.